James Featherstone

1.3k total citations
6 papers, 122 citations indexed

About

James Featherstone is a scholar working on Molecular Biology, Rheumatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, James Featherstone has authored 6 papers receiving a total of 122 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 1 paper in Rheumatology and 1 paper in Public Health, Environmental and Occupational Health. Recurrent topics in James Featherstone's work include Angiogenesis and VEGF in Cancer (1 paper), Sympathectomy and Hyperhidrosis Treatments (1 paper) and Metabolomics and Mass Spectrometry Studies (1 paper). James Featherstone is often cited by papers focused on Angiogenesis and VEGF in Cancer (1 paper), Sympathectomy and Hyperhidrosis Treatments (1 paper) and Metabolomics and Mass Spectrometry Studies (1 paper). James Featherstone collaborates with scholars based in Australia and United Kingdom. James Featherstone's co-authors include and has published in prestigious journals such as Nature Reviews Drug Discovery.

In The Last Decade

James Featherstone

6 papers receiving 114 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Featherstone Australia 6 61 21 17 14 14 6 122
Luis Llamas China 8 96 1.6× 8 0.4× 37 2.2× 24 1.7× 3 0.2× 8 173
Stephanie L. Stout United States 4 41 0.7× 5 0.2× 19 1.1× 21 1.5× 14 1.0× 5 95
Brendan J. Floyd United States 5 171 2.8× 30 1.4× 4 0.2× 14 1.0× 8 0.6× 7 219
Martyna Maszota‐Zieleniak Poland 10 141 2.3× 33 1.6× 26 1.5× 34 2.4× 6 0.4× 26 213
Jin-Xiong She China 6 49 0.8× 20 1.0× 29 1.7× 12 0.9× 3 0.2× 12 125
Xinjun Zhao China 4 118 1.9× 12 0.6× 4 0.2× 25 1.8× 6 0.4× 11 209
Neil Garton United Kingdom 7 119 2.0× 7 0.3× 102 6.0× 14 1.0× 3 0.2× 12 231
M. Szklarz United Kingdom 3 102 1.7× 6 0.3× 22 1.3× 25 1.8× 2 0.1× 3 180
Christian Perez United States 6 143 2.3× 17 0.8× 54 3.2× 64 4.6× 2 0.1× 8 221
Ron‐Patrick Cadeddu Germany 10 80 1.3× 8 0.4× 8 0.5× 35 2.5× 3 0.2× 19 253

Countries citing papers authored by James Featherstone

Since Specialization
Citations

This map shows the geographic impact of James Featherstone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Featherstone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Featherstone more than expected).

Fields of papers citing papers by James Featherstone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Featherstone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Featherstone. The network helps show where James Featherstone may publish in the future.

No nodes

All Works

6 of 6 papers shown
1.
Featherstone, James, et al.. (2005). Rheumatoid arthritis market. Nature Reviews Drug Discovery. 4(1). 11–12. 25 indexed citations
2.
Featherstone, James, et al.. (2004). The licensing gamble: raising the stakes. Nature Reviews Drug Discovery. 3(2). 107–108. 11 indexed citations
3.
Featherstone, James, et al.. (2003). The painful reality. Nature Reviews Drug Discovery. 2(3). 175–176. 37 indexed citations
4.
Featherstone, James, et al.. (2002). Structural proteomics. Nature Reviews Drug Discovery. 1(3). 175–176. 30 indexed citations
5.
Featherstone, James, et al.. (2002). Antiviral market overview. Nature Reviews Drug Discovery. 1(1). 11–12. 9 indexed citations
6.
Featherstone, James, et al.. (2002). Drugs that target angiogenesis. Nature Reviews Drug Discovery. 1(6). 413–414. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026